AGP Executive Report
Last update: 10 hours agoPTSD Treatment Breakthrough (Germany): Charité researchers report in Nature Medicine that a prescription THC-containing medication helped more than half of participants respond, with over a third seeing complete disappearance of PTSD nightmares—an option that could address limits of standard drug approaches. Extreme Heat Health Warning (Europe/Bulgaria): Bulgarian immunologist Petya Dimitrova warns that longer heatwaves and droughts strain thermoregulation and can worsen inflammation and chronic conditions, with cardiovascular patients facing higher summer mortality risk. Heat Death Toll (Germany): Multiple reports this week put Germany’s 2026 heat-related deaths close to (and in some coverage near) the 10,000 mark, underscoring the public-health pressure from record temperatures. Drug Safety vs Scams: A new report highlights the rise of “cancer cures” promoted on social media using repurposed antiparasitic drugs like ivermectin—fueling demand despite lack of proven benefit. Healthcare Access & Capacity: Coverage also flags ongoing gaps in public dental care, with demand outpacing capacity. Medical Cannabis (PTSD): The THC-nightmare study adds momentum to Germany’s broader debate on medical cannabis use.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Generative AI In Clinical Trials Market Size/Share Worth USD 1.86 Billion by 2035 at a 9.63% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/21273967-731329129-cmi-logo-png-100x51.png){kind=logo}
